Mass Spectrometry & Spectroscopy
What Exactly is Bile?
Mar 23 2020 Read 898 Times
A study from Michigan State University (MSU) has shed new light on bile, an acidic body fluid that's produced in the liver and released into the intestine during food consumption. The findings were published in the journal Nature and explain how the team discovered a new strain of bile acids produced not by enzymes but by microbes in the gut.
Bile acid was first discovered in 1848 by German scientist Heinrich Otto Wieland, who was awarded a Nobel Prize in 1928 for his research into the molecular structure of the fluid. Over the following decades researchers such as Robert Quinn, lead author of the study and assistant professor of biochemistry and molecular biology at MSU, have continued to explore the properties and functions of bile.
"Since then, our understanding of the chemistry of bile production in the liver was that the cholesterol backbone of the bile acid structure is linked to the amino acids glycine or taurine to produce our primary bile acids," says Quinn. "It begs the question of how the new bile acids we've discovered have remained hidden during the last 170 years of bile acid chemical research."
New bile acids produced by gut microbes
Unlike the bile discovered by Wieland, the new bile acids are created by microbes in the gut. The study explains how the cholesterol backbone conjugates with other amino acids in the gut to exchange genetic material create unique bile acids. For Quinn and his team, the discovery unlocks new insight into how the digestive system works and highlights the importance of the gut microbiome.
"These molecules can alter signalling pathways in the human gut that result in a reduction of overall bile acid production, representing a new mechanism where our gut bacteria can manipulate our own physiology," says Quinn.
Paving the way for new gastrointestinal disease research
Levels of the new bile acids were higher in the guts of patients suffering from gastrointestinal diseases such as cystic fibrosis and Crohn's disease, suggesting the study could be used to develop new treatments. "Clearly, our understanding of these compounds is in its infancy," says Quinn. "This exciting new discovery opens more questions than answers about these compounds and their role in our health."
New technologies play a pivotal role in supporting new research and developing biopharmaceutical products. To find out more about the latest native mass spectrometry (MS) developments don't miss 'Comprehensive Characterisation of Monoclonal Antibodies Using Charge Variant Analysis Coupled to High-Resolution Mass Spectrometry', which offers commentary from experts at Thermo Fisher Scientific (UK) Ltd.
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In This Edition Articles - Export experts talk Corona Virus - Automated cell counting shouldn’t cost the earth Laboratory Products - Spectrophotometer Linearity Validation - Analysi...
View all digital editions
Jun 11 2020 Brussels, Belgium
Jun 20 2020 San Diego, CA, USA
Jun 30 2020 Nuremberg, Germany
Jul 27 2020 Kintex, South Korea
Aug 02 2020 Milwaukee, Wisconsin, USA